v3.26.1
Balance Sheet Components
 6 Months Ended
Jun. 30, 2026
Inventory Disclosure [Abstract]  
Balance Sheet Components Balance Sheet Components
Inventories consist of the following as of the periods indicated:

(in thousands)June 30, 2026December 31, 2025
Raw materials$19,361 $18,546 
Finished goods27,481 29,466 
Total inventories $46,842 $48,012 
Accrued payroll-related expenses consist of the following as of the periods indicated:

(in thousands)June 30, 2026December 31, 2025
Accrued compensation and payroll taxes
$8,330 $17,905 
Accrued sales commissions3,207 4,791 
Accrued benefits1,577 2,251 
Total accrued payroll-related expenses$13,114 $24,947 

Other accrued expenses consist of the following as of the periods indicated:

(in thousands)June 30, 2026December 31, 2025
Securities class action settlement$18,000 $700 
Sales and VAT tax payables3,273 3,571 
Accrued interest2,862 2,929 
Royalty liabilities1,490 1,571 
Deferred revenue1,165 1,012 
Other4,815 5,601 
Total other accrued expenses$31,605 $15,384 
As of June 30, 2026 and December 31, 2025, total warranty reserve was approximately $1 million, which was included in other accrued expenses on the Condensed Consolidated Balance Sheets.
As of June 30, 2026 and December 31, 2025, the Company has approximately $2 million in restricted cash held as collateral for the Company’s credit cards, which was included in cash, cash equivalents and restricted cash on the Condensed Consolidated Balance Sheets.
During the six months ended June 30, 2026, the Company amended the terms of its principal executive office lease agreement to expire in November 2032, resulting in an increase of approximately $14 million in future operating lease payments and an approximately $10 million increase in lease-related balances on the Condensed Consolidated Balance Sheets.
As of June 30, 2026, the Company recorded a liability of $18.0 million in other accrued expenses and $15.0 million in prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets related to the settlement amount to be paid to the plaintiffs and insurance recovery from the Company’s insurers, respectively, related to the proposed settlement the Company has reached with plaintiffs in the Securities Class Action (as defined in Note 6 – Commitments and Contingencies – Securities Class Action). See Note 6 – Commitments and Contingencies – Securities Class Action, in this Quarterly Report on Form 10-Q for additional information with respect to the Securities Class Action.